Effect of betamethasone, indomethacin and Fenoterol (cas 13392-18-2) on neonatal and maternal mononuclear cells stimulated with Escherichia coli

Add time:07/28/2019    Source:sciencedirect.com

Despite considerable progress in the field of perinatal care, infectious diseases, especially when caused by gram negative bacteria, remain a major reason for neonatal morbidity and mortality. Notably infants born prematurely and those with very low birth weight are at risk due to their immature and deficient immune system and their prolonged hospitalization which promotes nosocomial infections. In case of impending preterm birth, betamethasone is given to induce lung maturation and tocolytic agents like indomethacin or Fenoterol (cas 13392-18-2) are administered to suppress premature labor. The aim of this study was to analyze the effects of these drugs on the immune system of mothers and neonates. Therefore, mononuclear cells from cord blood and peripheral maternal blood were stimulated with Escherichia coli and incubated with betamethasone, indomethacin and fenoterol. Subsequently the effect of the treatment on cytokine production was determined. Betamethasone alone and in combination with tocolytic agents inhibited the production of pro- and anti-inflammatory cytokines. Not only does betamethasone dampen the immune response by reducing the production of cytokines, it also has a variety of other detrimental short- and long-term effects on the neonate. In conclusion we would recommend using biological markers to determine if premature labor actually leads to preterm birth and subsequently administer betamethasone only to mothers giving birth prematurely.

We also recommend Trading Suppliers and Manufacturers of Fenoterol (cas 13392-18-2). Pls Click Website Link as below: cas 13392-18-2 suppliers

Prev:Effects of Fenoterol (cas 13392-18-2) on the skeletal system depend on the androgen level
Next:In vitro transdermal permeation of Fenoterol (cas 13392-18-2) hydrobromide)